Viemed Healthcare, Inc.
$9.66
▲
0.42%
2026-04-21 10:08:01
www.viemed.com
NCM: VMD
Explore Viemed Healthcare, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$372.9 M
Current Price
$9.66
52W High / Low
$10.06 / $5.93
Stock P/E
24.97
Book Value
$3.72
Dividend Yield
—
ROCE
13.1%
ROE
11.11%
Face Value
—
EPS
$0.37
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
1,382
Beta
1.16
Debt / Equity
11.11
Current Ratio
1.18
Quick Ratio
1.06
Forward P/E
23.77
Price / Sales
1.36
Enterprise Value
$371.53 M
EV / EBITDA
7.37
EV / Revenue
1.38
Rating
None
Target Price
$13
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bioventus Inc. | $10.28 | 38.48 | $874.79 M | — | 10.76% | 13.17% | $10.76 / $5.81 | $2.74 |
| 2. | Senseonics Holdings, Inc. | $6.87 | — | $287.13 M | — | -67.05% | -1.68% | $15.74 / $5.25 | $1.48 |
| 3. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
| 4. | GE HealthCare Technologies Inc. | $71.58 | 15.76 | $32.85 B | 0.19% | 9.93% | 22.38% | $89.77 / $59.95 | $22.77 |
| 5. | Profusa, Inc. | $0.66 | — | $3.05 M | — | 8.32% | 8.05% | $957 / $0.41 | $-61.03 |
| 6. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 7. | Apyx Medical Corporation | $3.94 | — | $166.48 M | — | -11.69% | -76.15% | $4.5 / $0.83 | $0.35 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 76.18 M | 71.91 M | 63.06 M | 59.13 M | 60.7 M | — |
| Operating Profit | 8.66 M | 6.12 M | 4.46 M | 1.47 M | 5.35 M | — |
| Net Profit | 5.64 M | 3.51 M | 3.16 M | 2.62 M | 4.32 M | — |
| EPS in Rs | 0.15 | 0.09 | 0.08 | 0.07 | 0.11 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 270.28 M | 224.26 M | 183.01 M | 138.83 M |
| Operating Profit | 20.71 M | 15.99 M | 14.97 M | 8.6 M |
| Net Profit | 14.93 M | 11.27 M | 10.24 M | 6.22 M |
| EPS in Rs | 0.39 | 0.29 | 0.27 | 0.16 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 199.15 M | 177.07 M | 154.9 M | 117.04 M |
| Total Liabilities | 55.63 M | 43.77 M | 41 M | 19.95 M |
| Equity | 141.54 M | 131.39 M | 113.89 M | 97.09 M |
| Current Assets | 48.49 M | 52.88 M | 38.37 M | 39.74 M |
| Current Liabilities | 41.06 M | 37.33 M | 32.12 M | 18.86 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 51.92 M | 39.09 M | 45.21 M | 27.75 M |
| Investing CF | -50.17 M | -30.7 M | -52.11 M | -23.98 M |
| Financing CF | -5.79 M | -3.69 M | 2.83 M | -15.27 M |
| Free CF | 11.93 M | 1.32 M | 19.12 M | 4.85 M |
| Capex | -39.98 M | -37.77 M | -26.09 M | -22.9 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 22.54% | 31.82% | — | — |
| Earnings Growth % | 9.98% | 64.63% | — | — |
| Profit Margin % | 5.02% | 5.6% | 4.48% | — |
| Operating Margin % | 7.13% | 8.18% | 6.19% | — |
| Gross Margin % | 59.4% | 61.63% | 60.99% | — |
| EBITDA Margin % | 18.87% | 20.04% | 17.88% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.